Whether you are watching television, scrolling through Instagram, or catching up with an old friend, the topic of weight loss ...

Explore Xeris Biopharma's revenue growth, promising pipeline, & thriving products. Learn about their strong outlook & ...

Glucagon-like peptide-1 (GLP-1 ... But the industry has only scratched the surface of what these drugs can do. A new range of drugs, currently in the research phase, aim to solve bottlenecks from the ...

Scientists have discovered a naturally occurring molecule that aids appetite control and weight loss so well, it may compete ...

The pharmaceutical industry is not stopping there. There are already 100 new drug candidates in trials, all vying for a slice ...

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy ...

By screening people for eating disorders and disordered eating before these medications are prescribed, we can prevent ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Researchers assess whether GLP-1 receptor agonists increase the risk of suicide, self-harm, or suicidal ideation in type 2 ...

But is it true? To understand this, the researchers studied if taking semaglutide, one of the new glucagon-like peptide-1 agonist (GLP-1 RAs) drugs, also known as Ozempic and Wegovy, before ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

A recent genetic study has provided new insights into how glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss. Read more!